ezetimibe medication used treat high blood cholesterol certain lipid generally used together dietary changes alone less preferred taken also available fixed combinations ezetimibebempedoic commonly reported adverse events include upper respiratory tract infections joint pain diarrhea serious side effects may include anaphylaxis liver problems depression muscle use pregnancy breastfeeding unclear ezetimibe works decreasing cholesterol absorption ezetimibe approved medical use united states available generic commonly prescribed medication united states million review found adding ezetimibe statin treatment high blood cholesterol effect overall mortality cardiovascular mortality although significantly reduced risk myocardial infarction trial found adding ezetimibe simvastatin effect overall mortality lower risk heart attack stroke people prior heart several treatment guidelines recommend adding ezetimibe select high risk persons ldl goals achieved maximally tolerated statin ezetimibe indicated united states addon dietary measures reduce levels certain lipids people review found ezetimibe used sole treatment slightly lowered plasma levels lipoproteina effect large enough ezetimibe improves nonalcoholic fatty liver disease activity score available evidence indicates improve outcomes hepatic two contraindications taking ezetimibe previous allergic reaction including symptoms rash angioedema anaphylaxis severe liver disease especially taken ezetimibe may significant medication interactions ciclosporin fibrates common adverse drug reactions patients associated ezetimibe therapy include headache andor diarrhea steatorrhea infrequent adverse effects patients include myalgia andor raised liver function test altast results rarely patients hypersensitivity reactions rash angioedema myopathy may cases muscle problems myalgia rhabdomyolysis reported included warnings label since also regulates vitamin k uptake use ezetimibe lead side effects warfarin incidence overdose ezetimibe rare subsequently data exist effects overdose however acute overdose ezetimibe expected produce exaggeration usual effects leading loose stools abdominal pain ezetimibe inhibits absorption cholesterol small intestine decreases amount cholesterol normally available liver cells lower levels cholesterol liver cells leads absorb cholesterol circulation thus lowering levels circulating cholesterol blocks critical mediator cholesterol absorption niemannpick protein gastrointestinal tract epithelial cells well hepatocytes blocks aminopeptidase n interrupts caveolin complex involved trafficking within hours oral administration dose fasting adults attained mean ezetimibe peak plasma concentration cmax ngml following oral administration ezetimibe absorbed extensively conjugated phenolic glucuronide active metabolite mean cmax ngml ezetimibeglucuronide attained within hours concomitant administration food highfat vs nonfat meals effect extent absorption ezetimibe however coadministration highfat meal increases cmax absolute bioavailability determined since ezetimibe insoluble aqueous media suitable injection ezetimibe active metabolites highly bound human plasma proteins ezetimibe primarily metabolized liver small intestine via glucuronide conjugation subsequent renal biliary parent compound active metabolite eliminated plasma halflife around hours allowing oncedaily dosing ezetimibe lacks significant inhibitor inducer effects cytochrome isoenzymes explains limited number drug interactions dose adjustment needed patients chronic kidney disease mild hepatic dysfunction childpugh score due insufficient data manufacturer recommend ezetimibe patients moderate severe hepatic impairment childpugh score patients mild moderate severe hepatic impairment mean auc values total ezetimibe increased respectively compared healthy httpsenwikipediaorgwikiezetimibe